Close

Refine your search

UEF flags.

Workshop on Biomarkers for Epilepsies and Neurodegenerative Diseases

A free pre-event to Kuopio Epilepsy Symposium 2024
  • Discussion event
  • Health and well-being
Event date:
Time:
10:00–13:00
Event location:
Kuopio City Theatre, Maria stage
Additional information:
Niiralankatu 2, 70600 Kuopio
Add to calendar:
Google Outlook iCal

During this workshop we will discuss shared and distinctive characteristics of changes in neuronal markers in various neurological disorders and consider the emerging opportunities and challenges for their future research and diagnostic use. Lessons learned from other therapeutic areas as well as diversity of perspectives are expected to result in the generation of fresh ideas and innovative solutions.

Our guest speaker, Professor Johan Zelano, introduces us to the topic with his remote talk on “Blood based biomarkers in epilepsies and neurodegenerative diseases”. Johan Zelano is a Professor of neurology at Sahlgrenska academy and a consultant neurologist at Sahlgrenska university hospital, Gothenburg, Sweden.

The event is intended for companies from start-ups and health tech to pharma, investors, researchers, and clinicians. The purpose of the event is to stimulate creativity and promote future collaboration.

A project funded by the European Regional Development Fund, Brain Research Unit 2.0, at the University of Eastern Finland, organizes this group discussion as a free pre-symposium event in connection with Kuopio Epilepsy Symposium 2024. Sanna-Kaisa Herukka, PhD, leader of the UEF Biomarker laboratory, hosts and moderates the event.

Come to share your ideas and perspectives with others. Register for the group discussion event by 1 March.

For further information, please contact Maria Pikkarainen, email maria.pikkarainen@uef.fi.

Related content

Research group picture: UEF Aivotutkimusyksikkö 2.0

UEF Brain Research Unit 2.0

Ongoing

The Brain Research Unit of the University of Eastern Finland (BRU) conducts high-quality clinical research as well as pharmaceutical research and collaboration with local, Finnish, and international research groups and the pharmaceutical industry. Specifically, the area of expertise in BRU includes biomarker studies, clinical trials and prevention studies of neurodegenerative diseases and cerebrovascular disorders. BRU also has the capability to investigate the genetic background, risk factors and basic mechanisms of brain diseases. Importantly, BRU has 20 years of experience, and it operates national and international collaborative networks. BRU with its collaborative network provides a service to the international or domestic pharmaceutical industry in research from the basic research to clinics. The aim of the UEF Brain Research Unit 2.0 ERDF project is to create a well-known, internationally attractive, and scalable operating model and brand in collaboration with UEF, KUH (Kuopio University Hospital) and companies. This strengthens the local Kuopio Health ecosystem and utilizes the extensive national and international network of the Neurocenter Finland and other stakeholders. The key operating processes will be strengthen based on the needs identified from business field by identifying bottlenecks, which are limiting cooperation as well as opportunities for new cooperation openings and partnering. Solution options are sought in ecosystem cooperation and tested by business-driven co-development (three piloting cases) and further development of internal processes and cooperation (three work packages), as well as identifying new commercialization potential in both organizational and operational environment level. UEF Brain Research Unit 2.0 is a new and scalable approach to multifunctional cooperation. The ERDF project creates, by further developing existing and new activities, nationally and internationally competitive forms of cooperation and structures that better serve the global the needs of pharmaceutical companies, equipment manufacturers, health technology operators and high-quality academic research. Furthermore, the project creates a plan to further develop activities, to meet the new updating needs created by the societal framework of clinical research and digitalization.

Read more